ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2017

Efficacy and safety of infliximab therapy in refractory upper respiratory tract sarcoidosis: experience from the STAT registry.

Thomas Barba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.